Printer Friendly

TOPOX AND APPLIED BIOSENSORS TO DEVELOP SKIN TISSUE MONITORING SYSTEM

TOPOX AND APPLIED BIOSENSORS TO DEVELOP SKIN TISSUE MONITORING SYSTEM
 CHADDS FORD, Pa., Sept. 11 /PRNewswire/ -- Topox, Inc. (AMEX: TPO.EC) and Applied Biosensors, Inc. (OTC Bulletin Board: APLB) today announced the signing of a letter of intent for a joint wound healing research and development effort.
 Dr. Jeffrey Hill, president and chief executive officer of Applied Biosensors, explained, "The proposed application will utilize our ultra sensitive, non-invasive, disposable tissue sensors to continuously monitor temperature, pH and oxygen diffusion near the wound site.
 Evelyna Dyson-Cantwell, president of Topox, said, "This technology should help us better understand the mechanism of action in wound healing. We are excited at the prospect of being able to boost the efficacy of our hyperbaric oxygen chamber treatments through instrument settings specific for each patient."
 Upon the execution of a mutually acceptable agreement, Topox will provide funding for the program and will be granted an exclusive option for the worldwide marketing rights to the sensor-based system to be supplied by Applied Biosensors. Preliminary clinical studies are in progress.
 Topox, Inc. develops and markets proprietary medical products which are used in the diagnosis, monitoring and ongoing treatment of skin disorders such as wounds, ulcerations, burns and other skin disorders including skin cancers and melanomas.
 Applied Biosensors, Inc. develops and manufactures proprietary sensor-based medical products that are designed to measure vital body chemicals in surgical patients and a variety of hospital, doctor's office and dental patients.
 /delval/
 -0- 9/11/92
 /CONTACT: George J. Stasen, COO/EVP of Topox, 800-388-6769, or Dr. Jeffrey Hill, president and CEO of Applied Biosensors, 201-347-7407/
 (TPO APLB) CO: Topox, Inc.; Applied Biosensors, Inc. ST: Pennsylvania, New Jersey IN: HEA SU: JVN


MK-LJ -- PH032 -- 8584 09/11/92 15:50 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Sep 11, 1992
Words:288
Previous Article:CANAL CAPITAL CORPORATION REPORTS THIRD QUARTER RESULTS
Next Article:DART GROUP CORPORATION ANNOUNCES SALES
Topics:


Related Articles
TOPOX REPORTS RESULTS FOR FISCAL YEAR ENDED MARCH 31, 1992
TOPOX ANNOUNCES RESULTS FOR THE FIRST QUARTER ENDED JUNE 30, 1992
TOPOX ANNOUNCES THE FDA HAS RULED FAVORABLY ON ITS 510K APPLICATION
TOPOX: AGREEMENT SIGNED TO MANUFACTURE INNOVATIVE MEDICAL DEVICES
TOPOX TO CHANGE NAME
TOPOX TO CHANGE NAME
NASA PROJECT TO FURTHER ULTRASOUND DIAGNOSTIC FRONTIERS
USBIOMATERIALS AND P.I. MEDICAL, TWO HI-TECH FIRMS, SHARE $1.25 MILLION CONTRACT
BIOSENSOR CORPORATION ANNOUNCES FIRST QUARTER RESULTS
Sontra Presents Promising Clinical Results in Patients with Diabetes from Glucose Monitoring Study.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters